Xanthohumol as an Adjuvant in the Treatment of Septic Shock

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

October 30, 2025

Study Completion Date

December 31, 2025

Conditions
Septic ShockPneumoniaARDS
Interventions
DIETARY_SUPPLEMENT

Xanthohumol

Patients, who received Xanthohumol (Chmiel-Xn-Active, SALUTIS Pharmacy, Poland) as adjunctive therapy to treatment recommended by Surviving Sepsis Campaign. Xanthohumol is administrated by the nosogastric tube three times a day \*every 8 hours) at the dose of 2 mg.\\/kg body weight for 10 days. The first dose of Xanthohumol is administrated within 4 hours after the admission to the ICU.

Trial Locations (1)

20-954

RECRUITING

Intensive Care Unit, University Hospital No 4,, Lublin

All Listed Sponsors
lead

Medical University of Lublin

OTHER